GLP-1 (Semaglutide) vs. Cagrilintide

When evaluating GLP-1 (Semaglutide) versus Cagrilintide for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.

When to prioritize GLP-1 (Semaglutide):

Select GLP-1 (Semaglutide) when the primary clinical objective aligns with its core mechanism: glp-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.. This is particularly relevant for protocols focused on significant weight loss via appetite suppression and metabolic improvement..

When to prioritize Cagrilintide:

Conversely, Cagrilintide is the superior choice when targeting long-acting amylin analog that activates amylin receptors in the hypothalamus to reduce food intake and slow gastric emptying., making it the preferred agent for appetite control and weight management, especially synergistic with glp-1 agonists..